Washington University School of Medicine led a study evaluating long-term gantenerumab treatment in individuals with ...
Washington University-led research shows a small group of participants in an Alzheimer’s study experienced a significant ...
An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...
For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...
Scientists report long-term gantenerumab use might prevent cognitive decline in people with genetic predisposition to ...
Randall J. Bateman, MD ... for the first time in a clinical trial – that early treatment to remove amyloid plaques from the brain many years before symptoms arise can delay the onset of ...
A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results